We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-7.29%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$8.42B
AUM Growth
+$741M
Cap. Flow
+$3.34B
Cap. Flow %
39.69%
Top 10 Hldgs %
82.38%
Holding
65
New
2
Increased
1
Reduced
5
Closed
2

Top Sells

Rank Stock Value
1
NET icon
Cloudflare
NET
+$224M
2
OPEN icon
Opendoor
OPEN
+$59.1M
3
DM
Desktop Metal, Inc.
DM
+$43.5M
4
UPST icon
Upstart Holdings
UPST
+$35.9M
5
COUR icon
Coursera
COUR
+$27.7M

Sector Composition

Rank Sector Weight
1 Healthcare 48.15%
2 Financials 37.79%
3 Consumer Staples 5.97%
4 Industrials 3.61%
5 Technology 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOOD icon
1
Robinhood
HOOD
$83.3B
$3.15B 37.4%
+74,818,398
New +$3.4B
NEUE
2
DELISTED
NeueHealth
NEUE
$1.78B 21.15%
2,727,652
COUR icon
3
Coursera
COUR
$1.68B
$502M 5.97%
15,867,769
-735,294
-4% -$27.7M
CVRX icon
4
CVRx
CVRX
$131M
$392M 4.66%
2,370,858
BGRY
5
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$269M 3.19%
+38,226,621
New +$327M
ALLK
6
DELISTED
Allakos
ALLK
$229M 2.72%
2,164,704
CRSP icon
7
CRISPR Therapeutics
CRSP
$4.68B
$178M 2.11%
1,590,002
GLUE icon
8
Monte Rosa Therapeutics
GLUE
$1.86B
$172M 2.04%
7,703,205
BILL icon
9
BILL Holdings
BILL
$4.62B
$150M 1.78%
560,774
AUPH icon
10
Aurinia Pharmaceuticals
AUPH
$1.92B
$114M 1.36%
5,172,683
TRIL
11
DELISTED
Trillium Therapeutics Inc.
TRIL
$101M 1.2%
5,736,363
NET icon
12
Cloudflare
NET
$93.7B
$100M 1.19%
889,759
-1,873,824
-68% -$224M
ADAP
13
DELISTED
Adaptimmune Therapeutics
ADAP
$88.3M 1.05%
17,082,611
MIRM icon
14
Mirum Pharmaceuticals
MIRM
$6.84B
$83.4M 0.99%
4,187,801
NKTX icon
15
Nkarta
NKTX
$159M
$80.8M 0.96%
2,904,974
OYST
16
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$70.2M 0.83%
5,925,287
RYTM icon
17
Rhythm Pharmaceuticals
RYTM
$7.41B
$64.2M 0.76%
4,912,306
VECT
18
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$51.8M 0.62%
67,069
AKUS
19
DELISTED
Akouos Inc
AKUS
$49.9M 0.59%
4,298,488
VTGN icon
20
VistaGen Therapeutics
VTGN
$9.55M
$44.7M 0.53%
543,420
ANNX icon
21
Annexon
ANNX
$814M
$43.9M 0.52%
2,358,606
-139,055
-6% -$2.82M
OKUR
22
OnKure Therapeutics
OKUR
$160M
$35.7M 0.42%
478,692
GRTX
23
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$35.3M 0.42%
4,362,986
MILE
24
DELISTED
Metromile, Inc. Common Stock
MILE
$33.3M 0.4%
9,384,285
-10
-0% -$56
SVRA icon
25
Savara
SVRA
$1.09B
$33.3M 0.4%
24,137,931

Similar funds

NEA Management Company's Q3 2021 Portfolio in Review

As of Q3 2021, NEA Management Company held 65 positions worth $8.42B, up 9.6% from $7.68B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

NEA Management Company deployed $3.34B of net new capital in Q3 2021, opening 2 new positions and adding to 1 existing holding. Its largest new stake was Robinhood: 74,818,398 shares worth $3.15B.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 79% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Cloudflare, an estimated $224M trimmed.

  • NEA Management Company's largest Q3 2021 buy was Robinhood: 74,818,398 shares worth $3.15B.
  • NEA Management Company added most to Inventiva in Q3 2021, an estimated $3.39M increase.
  • NEA Management Company's biggest Q3 2021 reduction was Cloudflare, cutting an estimated $224M.
  • NEA Management Company fully exited Opendoor in Q3 2021, selling an estimated $59.1M.
  • NEA Management Company's ten largest holdings make up 82% of its $8.42B portfolio in Q3 2021.
  • NEA Management Company opened 2 new positions and closed 2 in Q3 2021.
  • NEA Management Company's portfolio value rose 9.6% quarter-over-quarter to $8.42B.

Based on NEA Management Company's 13F filing for Q3 2021, filed 12 Nov 2021.